Search Results 21-30 of 27103 for monoclonal antibody
This is a multicenter, open-label, first-in-human Phase 1 study evaluating the anti-TIM-3 (T cell immunoglobulin and mucin containing protein-3) antibody TSR- ...
Medicines known as monoclonal antibodies may prevent beta-amyloid from clumping into plaques. ... The monoclonal antibody solanezumab did not show benefits for ...
Monoclonal antibodies, such as anti-endoglin monoclonal antibody TRC105 and bevacizumab, may find tumor cells and help kill them. Giving anti-endoglin ...
When bone marrow produces an unusual protein in the blood, it can sometimes lead to certain types of blood cancer.
Patients with antibodies to Hu-Mik-Beta-1; A contraindication to monoclonal antibody therapy including adverse events related to prior monoclonal antibody ...
Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as dinutuximab, may find ...
The purpose of this study is to compare the change in pain intensity during treatment with a CGRP monoclonal antibody (eptinezumab) compared with placebo ...
A Study to Assess the Safety, Tolerability and Effectiveness of Monoclonal Antibodies to Treat Hospitalized Patients with COVID-19 · Share · Facebook · Twitter.
Monoclonal antibody treatment. Monoclonal antibodies are basically antibodies that will attach to the spike protein of the SARS-CoV-2 virus (the virus that ...
A Study to Determine the Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies. Print details.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift now and help create new and better solutions for more than 1.3 million patients who turn to Mayo Clinic each year.